Tutorials › Statistical Genetics › Common Errors in Interpreting G×E Results

Gene–Environment Interaction · Tutorial 811 of 989

Common Errors in Interpreting G×E Results

Learn to distinguish a statistical G×E interaction from a causal claim, and to interpret tests and estimates on the scale they actually address.

Advanced 9 min read

What You'll Learn

  • Distinguish statistical interaction from causal interaction and identify what additional assumptions a causal interpretation requires
  • Explain why a nonsignificant interaction test does not establish the absence of effect modification
  • Compare stratum-specific effects using a direct contrast and its standard error
  • Recognize why comparing p-values across exposure strata is not a test of interaction
  • Interpret interaction results on the stated outcome and effect scale
  • Identify common errors in reporting G×E findings and replace them with accurate conclusions

Why Interpretation Requires More Than a Significant Result

A reported gene–environment (G×E) result can be statistically correct and still be interpreted incorrectly. A product-term test may address whether a model’s fitted genetic association varies across exposure levels; it does not, by itself, show that the exposure caused the variation. A nonsignificant test does not prove that the association is constant, and different p-values in separate strata do not establish that the stratum-specific effects differ. Even the meaning of “interaction” depends on the outcome and effect scale used.

These distinctions matter because G×E analyses often involve conditional estimates, several possible scales, and uncertainty that can be substantial in particular genotype–exposure groups. Interpretation should begin with the model, the contrast being tested, and the uncertainty around that contrast—not with a binary label of “significant” or “not significant.”

Definition: A statistical G×E interaction is a departure from the specified no-interaction model on a stated scale. It describes how an association or effect for genotype \(G\) varies with environment or exposure \(E\), as represented by that model. Statistical interaction is not, on its own, evidence that either factor causes the outcome or that the factors interact through a particular biological mechanism.

Interaction Is Not the Same as Causation

For a quantitative outcome, one familiar model with binary \(G\) and \(E\), each coded 0 or 1, is

$$ E(Y\mid G,E)=\beta_0+\beta_GG+\beta_EE+\beta_{GE}GE. $$

Here, \(\beta_G\) is the fitted difference in mean outcome between \(G=1\) and \(G=0\) when \(E=0\). When \(E=1\), that fitted difference is \(\beta_G+\beta_{GE}\). Thus \(\beta_{GE}\) is the difference between those two genetic associations, in the outcome’s units. This is an interpretation of the model’s conditional means. It becomes a causal interpretation only if the design and assumptions support causal estimation, including appropriate control of confounding, valid measurement, and the required assumptions about selection and model specification.

In observational data, genotype and exposure groups can differ in ways that matter for the outcome. Population structure, exposure-related social or clinical factors, selection into the study, or other sources of bias can contribute to observed conditional associations. Adjusting for measured covariates may help, but adjustment alone does not guarantee that all relevant assumptions hold. A small p-value for \(\beta_{GE}\) is evidence against the model’s no-interaction null under the analysis assumptions; it is not evidence that changing \(E\) would change the genetic effect.

Worked Example: A Product Term Does Not Establish a Causal Mechanism

Suppose a hypothetical observational study models a lung-function measure, in liters, using carrier status \(G\) and a binary occupational exposure \(E\). The fitted model is

$$ E(Y\mid G,E)=3.20-0.10G-0.20E+0.30GE, \qquad SE(\hat{\beta}_{GE})=0.10. $$

The estimated genetic association among unexposed participants is \(-0.10\) L per carrier-status contrast. Among exposed participants it is \(-0.10+0.30=0.20\) L. The estimated difference between these associations is therefore \(0.20-(-0.10)=0.30\) L, equal to \(\hat{\beta}_{GE}\). A Wald statistic is \(z=0.30/0.10=3.00\), giving a two-sided standard-normal p-value of approximately 0.00270.

This is evidence, under the fitted model and its inferential assumptions, against the null that the modeled genetic associations are equal across the two exposure groups. It does not show that the occupational exposure caused the difference, nor does it establish a biological mechanism. The study is observational, so a causal statement would require additional design and identification assumptions that this coefficient and p-value do not supply.

Nonsignificance Is Not Evidence of No Effect Modification

An interaction test asks whether the data are sufficiently incompatible with a specified null value, commonly \(\beta_{GE}=0\) for a product term. Its p-value depends both on the estimated interaction and on its standard error. A nonsignificant result can arise because the estimated interaction is small, because it is estimated imprecisely, or both. In G×E analyses, limited sample size or sparse genotype–exposure cells can make interaction estimates particularly uncertain.

A confidence interval helps show which interaction values remain reasonably compatible with the data. A wide interval that includes zero may also include materially positive and negative interactions; it does not establish that meaningful effect modification is absent. To support a claim that effects are sufficiently similar for a particular purpose, one would need to define what size of difference matters and use an analysis designed to assess that criterion. Merely failing to reject a zero-interaction null does not do this.

Worked Example: An Imprecise Interaction Estimate

In a hypothetical analysis of a quantitative trait measured in score points, the fitted interaction estimate is \(0.40\) points with \(SE=0.50\). Suppose a Wald interval uses the large-sample normal critical value 1.96. The test statistic and two-sided p-value are

$$ z=\frac{0.40}{0.50}=0.80, \qquad p=2P(Z\geq 0.80)\approx 0.4237, \quad Z\sim N(0,1). $$

The 95% Wald confidence interval is

$$ 0.40\pm1.96(0.50) =0.40\pm0.98 =[-0.58,\;1.38]\text{ points}. $$

The test does not reject a zero interaction at the 0.05 level. But the interval includes both a modest negative difference and a positive difference as large as 1.38 points. The result is inconclusive about whether effect modification exists at those magnitudes; it is not proof that the genetic association is identical across exposure levels. The interval’s interpretation is that the procedure, under its assumptions, would cover the fixed interaction parameter in 95% of repeated samples—not that there is a 95% probability this particular interval contains it.

Compare Effects Directly, Not Their P-Values

A common error is to test the genetic association separately in each exposure stratum, observe a significant result in one and a nonsignificant result in the other, and conclude that the effects differ. Those tests address separate null hypotheses: whether each stratum-specific association equals zero. Effect modification instead concerns whether the associations differ from each other. The appropriate test is a direct contrast of the estimates, with uncertainty calculated for that contrast.

For estimates \(\hat{\theta}_1\) and \(\hat{\theta}_0\) from two exposure strata, let \(\hat{\delta}=\hat{\theta}_1-\hat{\theta}_0\). The variance of a difference is

$$ \operatorname{Var}(\hat{\delta}) = \operatorname{Var}(\hat{\theta}_1) +\operatorname{Var}(\hat{\theta}_0) -2\operatorname{Cov}(\hat{\theta}_1,\hat{\theta}_0). $$

If the estimates are independent, their covariance is zero, and the standard error of the difference is the square root of the sum of their variances. If they are not independent, the covariance must be included. This follows because subtracting estimates changes the variance according to \(\operatorname{Var}(A-B)=\operatorname{Var}(A)+\operatorname{Var}(B)-2\operatorname{Cov}(A,B)\). A direct contrast therefore accounts for the uncertainty in both estimates and, where relevant, their dependence.

Worked Example: Different Stratum P-Values, No Significant Difference

Consider a hypothetical quantitative outcome measured in score points. Separate analyses estimate the genetic association as \(0.10\) points in the unexposed stratum, with \(SE=0.30\), and \(0.50\) points in the exposed stratum, also with \(SE=0.30\). Assume the two estimates come from disjoint strata and are independent, and use two-sided Wald tests with a standard-normal reference distribution.

The exposed-stratum test statistic is \(0.50/0.30=1.6667\), with two-sided p-value approximately 0.0956. The unexposed-stratum statistic is \(0.10/0.30=0.3333\), with two-sided p-value approximately 0.7389. Neither result alone tests whether the two genetic associations differ.

The estimated difference is

$$ \hat{\delta}=0.50-0.10=0.40\text{ points}. $$

Independence gives

$$ SE(\hat{\delta}) =\sqrt{0.30^2+0.30^2} =\sqrt{0.18} \approx0.4243\text{ points}. $$

Thus \(z=0.40/0.4243\approx0.9428\), with two-sided p-value approximately 0.3458. The 95% Wald interval is \(0.40\pm1.96(0.4243)\), or approximately \([-0.4316,\;1.232]\) points. The data do not provide strong evidence that the two stratum-specific associations differ, despite their different p-values. This does not establish that the associations are equal; the interval still allows differences in either direction.

Always Name the Scale

“Interaction” is incomplete unless the scale is specified. For a quantitative outcome, the linear-model product term describes departure from additivity of conditional means. For a binary outcome, additive interaction can refer to a departure from additivity of risks, whereas multiplicative interaction can refer to a departure from multiplicativity of risk ratios or odds, depending on the model. These are different contrasts. A finding of interaction on one scale need not imply interaction on another.

The scale also determines the interpretation of the numerical estimate. A coefficient on the mean scale is in outcome units; a log-scale coefficient is on a logarithmic scale; and a risk-scale contrast is expressed in risk differences or a related risk measure. Reports should name the outcome, the scale, the reference coding, and the contrast. Avoid describing a model coefficient simply as “the G×E effect” when that would leave its meaning ambiguous.

Worked Example: Additive and Multiplicative Risk Contrasts

Suppose a hypothetical study estimates the following risks of an outcome for four genotype–exposure groups: \(p_{00}=0.10\), \(p_{10}=0.20\), \(p_{01}=0.20\), and \(p_{11}=0.35\), where the first index is \(G\) and the second is \(E\). These values are assumed to be valid estimates for illustration.

On the additive risk scale, the interaction contrast is the joint-group risk minus the two single-factor increments, relative to the reference group:

$$ p_{11}-p_{10}-p_{01}+p_{00} =0.35-0.20-0.20+0.10 =0.05. $$

The estimated additive departure is 0.05, or 5 percentage points. For a multiplicative contrast using risk ratios relative to \(p_{00}\), the joint-group risk ratio is \(0.35/0.10=3.5\); the single-factor risk ratios are each \(0.20/0.10=2.0\). Their multiplicative interaction ratio is

$$ \frac{p_{11}/p_{00}} {(p_{10}/p_{00})(p_{01}/p_{00})} = \frac{3.5}{2.0\times2.0} =0.875. $$

The additive contrast is positive, while the multiplicative ratio is below 1. They answer different questions, so these results are not contradictory. Neither calculation, without appropriate design and assumptions, makes a causal claim. A report should say which contrast it estimated rather than treating “interaction” as a scale-free property.

A Practical Interpretation Check

Before drawing a conclusion from a G×E result, work through the following sequence. It prevents the most common interpretive shortcuts while keeping attention on the scientific quantity actually estimated.

1
Identify the estimand and scale.
State the outcome, the model, the genotype and exposure coding, and whether the contrast concerns means, risks, risk ratios, odds, or another quantity.
2
Read the direct interaction contrast.
Determine exactly which difference or departure is tested. Do not substitute a comparison of separate stratum p-values for this contrast.
3
Assess uncertainty and magnitude.
Use the estimate and its standard error or confidence interval. A nonsignificant p-value alone does not show that meaningful effect modification is absent.
4
Limit the conclusion to what the design supports.
Describe an association as an association unless the design and causal assumptions justify a causal interpretation.

Common Mistakes

  • Wrong: “The interaction p-value is small, so exposure causes the genetic effect to change.” Correction: The test concerns a model-defined statistical contrast. A causal claim requires design and assumptions that address confounding, selection, measurement, and model validity.
  • Wrong: “The interaction is nonsignificant, so there is no effect modification.” Correction: Nonsignificance means the test did not reject its null at the chosen level. Inspect the estimate and interval; imprecision may leave important differences plausible.
  • Wrong: “The genetic effect is significant in one stratum but not the other, so the effects differ.” Correction: Test the difference directly, using its standard error and the covariance structure of the estimates.
  • Wrong: “There is a G×E interaction,” without naming the scale. Correction: State whether the result concerns, for example, additive mean differences or multiplicative risk ratios, and give the contrast’s units or interpretation.
Key takeaway: Interpret a G×E result as a model- and scale-specific contrast with uncertainty. A significant interaction test does not by itself establish causation; a nonsignificant test does not establish no effect modification; and stratum-specific p-values do not test whether stratum-specific effects differ.

Check Your Understanding

For each question, identify the quantity being tested before deciding what conclusion is justified.

  1. A product-term test is significant in an observational study. What can the test support, and what additional reasoning is needed for a causal claim?
  2. An interaction estimate has a confidence interval that includes zero and also includes large positive values. Why is it inaccurate to conclude that effect modification is absent?
  3. One exposure stratum has a significant genetic association and another has a nonsignificant association. What contrast should be tested to assess whether the associations differ?
  4. Why can additive interaction in risks and multiplicative interaction in risk ratios give different conclusions for the same four group risks?
  5. What information should accompany a reported interaction coefficient so that its meaning is clear?
Clinical Biostats